Power Corp Of Canada Vertex Pharmaceuticals Inc Transaction History

Power Corp Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $325,507 - $389,735	-949 Reduced 6.28%	14,156 $5.76 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $4.75 Million - $5.32 Million	15,105 New	15,105 $5.32 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $4.32 Million - $4.93 Million	15,261 New	15,261 $4.81 Million
Q3 2022 Nov 18, 2022	BUY	$273.83 - $305.53 $285,604 - $318,667	1,043 New	1,043 $302,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $843,167 - $993,773	3,808 New	3,808 $994,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

Stay updated on Power Corp Of Canada with notifications on news.